We are live on
!
Find out more
Vanguard Investments Australia Portfolio holdings
AUM
$40.2B
This Fund
S&P 500
This Quarter
Est. Return
-0.63%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$34.6B
AUM Growth
–
Cap. Flow
+$36B
Cap. Flow
% of AUM
103.96%
Top 10 Holdings %
Top 10 Hldgs %
31.34%
Holding
2,379
New
2,379
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.22B |
| 2 |
Apple
AAPL
|
+$1.91B |
| 3 |
Microsoft
MSFT
|
+$1.48B |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.25B |
| 5 |
Amazon
AMZN
|
+$1.06B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.25% |
| 2 | Financials | 11.63% |
| 3 | Consumer Discretionary | 8.93% |
| 4 | Communication Services | 8.9% |
| 5 | Healthcare | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Tenable Holdings
TENB
$3.85B
| $471K | ﹤0.01% |
+27,867
| New | +$585K |
|
1602
Insight Enterprises
NSIT
$4.57B
| $471K | ﹤0.01% |
+7,024
| New | +$574K |
|
1603
Levi Strauss
LEVI
$7.6B
| $470K | ﹤0.01% |
+25,445
| New | +$521K |
|
1604
KE Holdings
BEKE
$18.3B
| $470K | ﹤0.01% |
+31,372
| New | +$539K |
|
1605
Lionsgate Studios
LION
$3.33B
| $466K | ﹤0.01% |
+48,543
| New | +$448K |
|
1606
Loar Holdings
LOAR
$5.95B
| $465K | ﹤0.01% |
+8,108
| New | +$547K |
|
1607
Atkore
ATKR
$3.2B
| $462K | ﹤0.01% |
+7,835
| New | +$509K |
|
1608
Ultragenyx Pharmaceutical
RARE
$1.51B
| $461K | ﹤0.01% |
+22,000
| New | +$495K |
|
1609
Hope Bancorp
HOPE
$1.72B
| $458K | ﹤0.01% |
+41,044
| New | +$474K |
|
1610
Arcus Biosciences
RCUS
$3.27B
| $458K | ﹤0.01% |
+21,207
| New | +$458K |
|
1611
Agios Pharmaceuticals
AGIO
$1.99B
| $458K | ﹤0.01% |
+13,537
| New | +$384K |
|
1612
Syndax Pharmaceuticals
SNDX
$1.63B
| $458K | ﹤0.01% |
+19,585
| New | +$426K |
|
1613
Nektar Therapeutics
NKTR
$2.02B
| $457K | ﹤0.01% |
+6,355
| New | +$362K |
|
1614
Liberty Global Class A
LBTYA
$3.16B
| $456K | ﹤0.01% |
+37,742
| New | +$439K |
|
1615
Celldex Therapeutics
CLDX
$2.48B
| $455K | ﹤0.01% |
+14,345
| New | +$391K |
|
1616
A10 Networks
ATEN
$1.87B
| $455K | ﹤0.01% |
+19,665
| New | +$385K |
|
1617
Peloton Interactive
PTON
$2.21B
| $453K | ﹤0.01% |
+105,686
| New | +$515K |
|
1618
Comstock Resources
CRK
$3.67B
| $453K | ﹤0.01% |
+21,504
| New | +$458K |
|
|
SEM
1619
DELISTED
Select Medical
SEM
| $453K | ﹤0.01% |
+27,805
| New | +$435K |
|
1620
Warby Parker
WRBY
$3.4B
| $452K | ﹤0.01% |
+21,476
| New | +$533K |
|
1621
Pilgrim's Pride
PPC
$6.49B
| $452K | ﹤0.01% |
+11,969
| New | +$483K |
|
1622
BlackLine
BL
$1.53B
| $451K | ﹤0.01% |
+12,191
| New | +$525K |
|
1623
Alarm.com
ALRM
$2.64B
| $450K | ﹤0.01% |
+10,414
| New | +$497K |
|
1624
Joby Aviation
JOBY
$5.97B
| $450K | ﹤0.01% |
+54,419
| New | +$613K |
|
1625
HCI Group
HCI
$2.2B
| $449K | ﹤0.01% |
+2,901
| New | +$475K |
|
Similar funds
VARA
SAM
CS
PPF
Vanguard Investments Australia's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Investments Australia, which disclosed 2,379 positions worth $34.6B. Its ten largest holdings account for 31% of the portfolio.
Its largest position is NVIDIA: 12,096,470 shares worth $2.11B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, followed by Financials and Consumer Discretionary.
- Vanguard Investments Australia's largest Q1 2026 buy was NVIDIA: 12,096,470 shares worth $2.11B.
- Vanguard Investments Australia's ten largest holdings make up 31% of its $34.6B portfolio in Q1 2026.
- Vanguard Investments Australia disclosed 2,379 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Investments Australia's 13F filing for Q1 2026, filed 8 May 2026.